A. Chetta (Parma, Italy), N. Tzanakis (Heraklion, Greece)
LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study P. W Jones, J. A Wedzicha, A. Agusti, M. Decramer, H. Muellerova, C. Q. Zhu, L. Adamek (London, Uxbridge, United Kingdom; Barcelona, Spain; Leuven, Belgium)
| |
The impact of chronic cough: A European perspective S. Chamberlain, S. Masefield, P. Powell, A. Douiri, R. Garrod, A. Morice, S. Birring (London, Sheffield, Hull, United Kingdom)
| |
The use of digitial devices to quantify air leak in pneumothorax G. Tunnicliffe, Y. E. Ong, A. Draper, L. Schomberg (London, United Kingdom)
| |
Emphysema and respiratory bronchiolitis (RB) on high resolution computed tomography of the thorax (HRCT) in smokers with normal spirometry R. Gil, M. Salinas, M. Florenzano, P. Bitar, I. Moyna (Santiago, Chile)
| |
Effectiveness and safety of tissue plasminogen activators (t-PA) in complicated pleural effusion (CPE), what the correlation with time it stays in the pleural space? M. Bashir, K. Mousbah, A. Gdeedo (Tripoli, Libyan Arab Jamahiriya)
| |
Applying age-adjusted cut offs to exclude thromboembolic disease with a semi-quantitative D-dimer assay can safely exclude VTE R. Shrimanker, N. Kalsi, A. Stanton (Swindon, United Kingdom)
| |
Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia A. Uranga, P. P. Espana, A. Capelastegui, R. Díez, A. Bilbao, C. Mar, E. Bereciartua (Galdakao, Bilbao, Spain)
| |
Pneumotox – An updated time-saving web resource P. Camus, P. Bonniaud, C. Camus, P. Foucher, L. Jacquet (Dijon, France)
| |